Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

William Adrian Hall MD

William Adrian Hall MD profile photo picture

Professor

Institution: Medical College of Wisconsin
Department: Radiation Oncology
Program: Clinical

Member of the Cancer Center

View Curriculum Vitae

Publications (210)

  • Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial (Westerhoff JM, Sanford NN, Hall WA) The Lancet Gastroenterology and Hepatology August 2024;9(8):687 SCOPUS ID: 2-s2.0-85197058786 08/01/2024    
  • SBRT for Pancreatic Cancer: A Radiosurgery Society Case-Based Practical Guidelines to Challenging Cases. (Liu J, Sidiqi B, McComas K, Gogineni E, Andraos T, Crane CH, Chang DT, Goodman KA, Hall WA, Hoffe S, Mahadevan A, Narang AK, Lee P, Williams TM, Chuong MD) Pract Radiat Oncol 2024 Jul 08 PMID: 38986901 SCOPUS ID: 2-s2.0-85200631491 07/11/2024    
  • Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial. (Westerhoff JM, Sanford NN, Hall WA) Lancet Gastroenterol Hepatol 2024 Aug;9(8):687 PMID: 38971163 SCOPUS ID: 2-s2.0-85197058786 07/07/2024    
  • Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocol (Grimbergen G, Eijkelenkamp H, Snoeren LMW, Bahij R, Bernchou U, van der Bijl E, Heerkens HD, Binda S, Ng SSW, Bouchart C, Paquier Z, Brown K, Khor R, Chuter R, Freear L, Dunlop A, Mitchell RA, Erickson BA, Hall WA, Godoy Scripes P, Tyagi N, de Leon J, Tran C, Oh S, Renz P, Shessel A, Taylor E, Intven MPW, Meijer GJ) Clinical and Translational Radiation Oncology July 2024;47 SCOPUS ID: 2-s2.0-85193854752 07/01/2024       3 Citations
  • Interobserver variation in tumor delineation of liver metastases using Magnetic Resonance Imaging. (Peltenburg JE, Hosni A, Bahij R, Boeke S, Braam PM, Hall WA, Intven MPW, Nicosia L, Sonke JJ, Witte M, Nowee ME, Janssen T) Phys Imaging Radiat Oncol 2024 Apr;30:100592 PMID: 38912009 PMCID: PMC11190710 SCOPUS ID: 2-s2.0-85194749626 06/24/2024    
  • Patient-Reported Outcomes Following Magnetic Resonance-Guided Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis. (Westerhoff JM, Lalmahomed TA, Meijers LTC, Henke L, Teunissen FR, Bruynzeel AME, Alongi F, Hall WA, Kishan AU, Intven MPW, Verkooijen HM, van der Voort van Zyp JRN, Daamen LA) Int J Radiat Oncol Biol Phys 2024 Sep 01;120(1):38-48 PMID: 38838994 SCOPUS ID: 2-s2.0-85201078176 06/06/2024    
  • Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocol. (Grimbergen G, Eijkelenkamp H, Snoeren LMW, Bahij R, Bernchou U, van der Bijl E, Heerkens HD, Binda S, Ng SSW, Bouchart C, Paquier Z, Brown K, Khor R, Chuter R, Freear L, Dunlop A, Mitchell RA, Erickson BA, Hall WA, Godoy Scripes P, Tyagi N, de Leon J, Tran C, Oh S, Renz P, Shessel A, Taylor E, Intven MPW, Meijer GJ) Clin Transl Radiat Oncol 2024 Jul;47:100797 PMID: 38831754 PMCID: PMC11145226 SCOPUS ID: 2-s2.0-85193854752 06/04/2024       3 Citations
  • Changes in Daily Apparent Diffusion Coefficient on Fully Quantitative Magnetic Resonance Imaging Correlate With Established Genomic Pathways of Radiation Sensitivity and Reveal Novel Biologic Associations. (Hall WA, Mathison AJ, DeVoe E, Tschannen M, Wendt-Andrae J, Straza M, Awan M, Puckett LL, Lawton CAF, Schultz C, Urrutia R, Kerns S, Torres-Roca JF, Li XA, Erickson B, Nevalainen MT, Zimmermann MT, Paulson E) Int J Radiat Oncol Biol Phys 2024 Oct 01;120(2):570-578 PMID: 38819340 SCOPUS ID: 2-s2.0-85194948255 05/31/2024    
  • Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series. (Mehdi M, Szabo A, Shreenivas A, Thomas JP, Tsai S, Christians KK, Evans DB, Clarke CN, Hall WA, Erickson B, Ahmed G, Thapa B, McFall T, George B, Kurzrock R, Kamgar M) Ther Adv Med Oncol 2024;16:17588359241253113 PMID: 38770091 PMCID: PMC11104030 SCOPUS ID: 2-s2.0-85193752803 05/21/2024       1 Citation
  • Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer. (Lee WR, Dignam JJ, Amin MB, Bruner DW, Low D, Swanson GP, Shah AB, D'Souza D, Michalski JM, Dayes IS, Seaward SA, Hall WA, Nguyen PL, Pisansky TM, Faria SL, Chen Y, Rodgers JP, Sandler HM) J Clin Oncol 2024 Jul 10;42(20):2377-2381 PMID: 38759121 PMCID: PMC11377096 SCOPUS ID: 2-s2.0-85197596307 05/17/2024    
  • ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer. (Alvarez J, Shi Q, Dasari A, Garcia-Aguilar J, Sanoff H, George TJ, Hong TS, Yothers G, Philip PA, Nelson GD, Al Baghdadi T, Alese O, Zambare W, Omer DM, Verheij FS, Buckley J, Williams H, George M, Garcia R, O'Reilly EM, Meyerhardt JA, Shergill A, Horvat N, Romesser PB, Hall WA, Smith JJ) medRxiv 2024 Apr 27 PMID: 38712176 PMCID: PMC11071544 05/07/2024    
  • MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study (Sritharan K, Daamen L, Pathmanathan A, Schytte T, Pos F, Choudhury A, van der Voort van Zyp JRN, Kerkmeijer LGW, Hall W, Hall E, Verkooijen HM, Herbert T, Hafeez S, Mitchell A, Tree AC) Clinical and Translational Radiation Oncology May 2024;46 SCOPUS ID: 2-s2.0-85186634434 05/01/2024    
  • Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy. (Westerhoff JM, Daamen LA, Christodouleas JP, Blezer ELA, Choudhury A, Westley RL, Erickson BA, Fuller CD, Hafeez S, van der Heide UA, Intven MPW, Kirby AM, Lalondrelle S, Minsky BD, Mook S, Nowee ME, Marijnen CAM, Orrling KM, Sahgal A, Schultz CJ, Faivre-Finn C, Tersteeg RJHA, Tree AC, Tseng CL, Schytte T, Silk DM, Eggert D, Luzzara M, van der Voort van Zyp JRN, Verkooijen HM, Hall WA) JAMA Netw Open 2024 May 01;7(5):e2410819 PMID: 38691356 PMCID: PMC11063805 SCOPUS ID: 2-s2.0-85192045091 05/01/2024    
  • Interobserver variation in tumor delineation of liver metastases using Magnetic Resonance Imaging (Peltenburg JE, Hosni A, Bahij R, Boeke S, Braam PM, Hall WA, Intven MPW, Nicosia L, Sonke JJ, Witte M, Nowee ME, Janssen T) Physics and Imaging in Radiation Oncology April 2024;30 SCOPUS ID: 2-s2.0-85194749626 04/01/2024    
  • Future direction of total neoadjuvant therapy for locally advanced rectal cancer. (Kagawa Y, Smith JJ, Fokas E, Watanabe J, Cercek A, Greten FR, Bando H, Shi Q, Garcia-Aguilar J, Romesser PB, Horvat N, Sanoff H, Hall W, Kato T, Rödel C, Dasari A, Yoshino T) Nat Rev Gastroenterol Hepatol 2024 Jun;21(6):444-455 PMID: 38485756 SCOPUS ID: 2-s2.0-85187897074 03/15/2024       2 Citations
  • Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study (Daamen LA, Westerhoff JM, Couwenberg AM, Braam PM, Rütten H, den Hartogh MD, Christodouleas JP, Hall WA, Verkooijen HM, Intven MPW) Clinical and Translational Radiation Oncology March 2024;45 SCOPUS ID: 2-s2.0-85182406191 03/01/2024       1 Citation
  • Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma. (George B, Kudryashova O, Kravets A, Thalji S, Malarkannan S, Kurzrock R, Chernyavskaya E, Gusakova M, Kravchenko D, Tychinin D, Savin E, Alekseeva L, Butusova A, Bagaev A, Shin N, Brown JH, Sethi I, Wang D, Taylor B, McFall T, Kamgar M, Hall WA, Erickson B, Christians KK, Evans DB, Tsai S) Gastroenterology 2024 May;166(5):859-871.e3 PMID: 38280684 SCOPUS ID: 2-s2.0-85188891214 01/28/2024       4 Citations
  • Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study. (Daamen LA, Westerhoff JM, Couwenberg AM, Braam PM, Rütten H, den Hartogh MD, Christodouleas JP, Hall WA, Verkooijen HM, Intven MPW) Clin Transl Radiat Oncol 2024 Mar;45:100721 PMID: 38274389 PMCID: PMC10808928 SCOPUS ID: 2-s2.0-85182406191 01/26/2024       1 Citation
  • Re-Examining Trials of Radiotherapy Omission: When Less Is Not Always More. (Sanford NN, Hall WA, Booth CM) JCO Oncol Pract 2024 Apr;20(4):460-462 PMID: 38237089 SCOPUS ID: 2-s2.0-85190481715 01/18/2024       1 Citation
  • The Use of MR-Guided Radiation Therapy for Pancreatic Cancer (Daamen LA, Parikh PJ, Hall WA) Seminars in Radiation Oncology January 2024;34(1):23-35 SCOPUS ID: 2-s2.0-85178168607 01/01/2024       1 Citation
  • Human-in-the-Loop Informed Deep Learning Rectal Tumor Segmentation on Pre-Treatment MRI (Kong M, DeSilvio T, Bao L, Flannery B, Parker BN, Tang S, Labbad M, O’Connor G, Gupta A, Steinhagen E, Purysko AS, Hall W, Liska D, Marderstein EL, Carroll A, Crittenden M, Gough M, Young K, Viswanath SE) Progress in Biomedical Optics and Imaging - Proceedings of SPIE 2024;12927 SCOPUS ID: 2-s2.0-85191429080 01/01/2024    
  • Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy. (de Ortiz de Choudens S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Madhavan S, Erickson BA, Hall WA) Cancer Med 2024 Jan;13(1):e6582 PMID: 38140796 PMCID: PMC10807686 SCOPUS ID: 2-s2.0-85180644976 12/23/2023    
  • The Use of MR-Guided Radiation Therapy for Pancreatic Cancer. (Daamen LA, Parikh PJ, Hall WA) Semin Radiat Oncol 2024 Jan;34(1):23-35 PMID: 38105090 SCOPUS ID: 2-s2.0-85178168607 12/18/2023       1 Citation
  • Development of a comprehensive cardiac atlas on a 1.5 Tesla Magnetic Resonance Linear Accelerator. (Schottstaedt AM, Paulson ES, Rubenstein JC, Chen X, Omari EA, Li XA, Schultz CJ, Puckett LL, Robinson CG, Alongi F, Gore EM, Hall WA) Phys Imaging Radiat Oncol 2023 Oct;28:100504 PMID: 38035207 PMCID: PMC10682663 SCOPUS ID: 2-s2.0-85176356378 11/30/2023       3 Citations
  • Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter Century. (Mheid S, Allen S, Ng SSW, Hall WA, Sanford NN, Aguilera TA, Elamir AM, Bahij R, Intven MPW, Radhakrishna G, Mohamad I, De Leon J, Tan H, Lewis S, Gani C, Stanecu T, Dell'Acqua V, Hosni A) Curr Oncol 2023 Oct 19;30(10):9230-9243 PMID: 37887567 PMCID: PMC10605011 SCOPUS ID: 2-s2.0-85175273499 10/27/2023    
  • Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac. (Eijkelenkamp H, Grimbergen G, Daamen LA, Heerkens HD, van de Ven S, Mook S, Meijer GJ, Molenaar IQ, van Santvoort HC, Paulson E, Erickson BA, Verkooijen HM, Hall WA, Intven MPW) Front Oncol 2023;13:1040673 PMID: 37854684 PMCID: PMC10579578 SCOPUS ID: 2-s2.0-85174581894 10/19/2023       3 Citations
  • Elucidating the Benefit of Radiation Therapy in GI Cancers: Rethinking Trial End Points and Patient Selection. (Sanford NN, Hong TS, Hall WA) J Clin Oncol 2024 Mar 10;42(8):868-871 PMID: 37856733 SCOPUS ID: 2-s2.0-85183912068 10/19/2023       3 Citations
  • Outcomes of Tolerability, Acute Toxicity and Quality of Life from MR-Guided Radiation Therapy (1.5T MR-Linac) for Liver Metastases in the MOMENTUM Study. (Westley R, Peltenburg J, Aitken KL, Awan MJ, Braam PM, Daamen LA, Hosni A, Intven MPW, Janssen T, Schytte T, Sonke JJ, Straza MW Jr, Paulson ES, Hall WA, Nowee ME) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e156 PMID: 37784746 10/03/2023    
  • Patient-Specific Deep Learning Auto-Segmentation for MR-Guided Adaptive Radiotherapy of Prostate Cancer. (Amjad A, Chen X, Hall WA, Lawton CAF, Li A, Paulson ES) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e638-e639 PMID: 37785902 10/03/2023    
  • Quality of Life in Prostate Cancer Patients Undergoing Daily Adaptive Versus Non-Adaptive Radiation Therapy Utilizing A 1.5 Tesla MR-Linac. (Ponce SEB, Daamen LA, Van der Voort vanZyp J, Westerhoff JM, Pos FJ, Christodouleas JP, Choudhury A, van der Heide U, Lawton CAF, Straza MW Jr, Bedi M, Paulson ES, Nasief HG, Li A, Verkooijen H, Tree A, Hall WA) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S114-S115 PMID: 37784299 10/03/2023    
  • Patterns of Locoregional Pancreatic Cancer Recurrence after Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes. (Ponce SEB, Small CJ, Ahmad T, Patel K, Tsai S, Kamgar M, George B, Kharofa JR, Saeed H, Dua KS, Clarke C, Aldakkak M, Evans DB, Christians K, Paulson ES, de Choudens SO, Erickson BA, Hall WA) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e284-e285 PMID: 37785058 10/03/2023    
  • Evolution of the MOMENTUM Study for Evidence-Based Implementation of MR-Guided Radiotherapy Using the 1.5 Tesla MR-Linac. (Daamen LA, Westerhoff JM, Christodouleas JP, Orrling K, Eggert D, Choudhury A, Fuller CD, van der Heide U, Sahgal A, Schultz CJ, Schytte T, Tersteeg R, Tree A, Hall WA, Verkooijen H) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e576-e577 PMID: 37785753 10/03/2023    
  • Patient-Reported Outcomes of Rectal Cancer Patients Treated on a 1.5T MR-Linac within the MOMENTUM Study. (Daamen LA, Westerhoff JM, Couwenberg AM, Braam PM, Rütten H, Christodouleas JP, Hall WA, Verkooijen H, Intven MPW) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e291 PMID: 37785076 10/03/2023    
  • Validation of a Genomic Classifier in the NRG Oncology/RTOG 0521 Phase III Trial of Docetaxel with Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer. (Phillips R, Proudfoot J, Davicioni E, Spratt DE, Feng FY, Simko J, Den RB, Pollack A, Rosenthal SA, Sartor O, Sweeney C, Attard G, Patel SI, Hall WA, Efstathiou JA, Shah AB, Hoffman KE, Pugh S, Sandler HM, Tran PT) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S34-S35 PMID: 37784480 10/03/2023    
  • Clinical Usability-Oriented Automatic Contour Quality Evaluation for Deep Learning Auto-Segmentation. (Zhang Y, Amjad A, Ding J, Sarosiek C, Zarenia M, Conlin R, Dang NP, Hall WA, Erickson BA, Paulson ES, Li A) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S144-S145 PMID: 37784368 10/03/2023    
  • Development of a comprehensive cardiac atlas on a 1.5 Tesla Magnetic Resonance Linear Accelerator (Schottstaedt AM, Paulson ES, Rubenstein JC, Chen X, Omari EA, Li XA, Schultz CJ, Puckett LL, Robinson CG, Alongi F, Gore EM, Hall WA) Physics and Imaging in Radiation Oncology October 2023;28 SCOPUS ID: 2-s2.0-85176356378 10/01/2023       3 Citations
  • Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability. (Sritharan K, Akhiat H, Cahill D, Choi S, Choudhury A, Chung P, Diaz J, Dysager L, Hall W, Huddart R, Kerkmeijer LGW, Lawton C, Mohajer J, Murray J, Nyborg CJ, Pos FJ, Rigo M, Schytte T, Sidhom M, Sohaib A, Tan A, van der Voort van Zyp J, Vesprini D, Zelefsky MJ, Tree AC) Int J Radiat Oncol Biol Phys 2024 Feb 01;118(2):378-389 PMID: 37633499 SCOPUS ID: 2-s2.0-85181813907 08/27/2023       1 Citation
  • Deep learning auto-segmentation on multi-sequence magnetic resonance images for upper abdominal organs. (Amjad A, Xu J, Thill D, Zhang Y, Ding J, Paulson E, Hall W, Erickson BA, Li XA) Front Oncol 2023;13:1209558 PMID: 37483486 PMCID: PMC10358771 SCOPUS ID: 2-s2.0-85165181686 07/24/2023       2 Citations
  • Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma. (Hall WA, Li J, You YN, Gollub MJ, Grajo JR, Rosen M, dePrisco G, Yothers G, Dorth JA, Rahma OE, Russell MM, Gross HM, Jacobs SA, Faller BA, George S, Al Baghdadi T, Haddock MG, Valicenti R, Hong TS, George TJ) J Clin Oncol 2023 Oct 10;41(29):4643-4651 PMID: 37478389 PMCID: PMC10564288 SCOPUS ID: 2-s2.0-85174713393 07/21/2023       9 Citations
  • X-ray and MR Contrast Bearing Nanoparticles Enhance the Therapeutic Response of Image-Guided Radiation Therapy for Oral Cancer. (Sharma G, Razeghi Kondelaji MH, Sharma GP, Hansen C, Parchur AK, Shafiee S, Jagtap JM, Fish B, Bergom C, Paulson E, Hall WA, Himburg HA, Joshi A) Technol Cancer Res Treat 2023;22:15330338231189593 PMID: 37469184 PMCID: PMC10363893 SCOPUS ID: 2-s2.0-85165292958 07/20/2023       3 Citations
  • Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA) Advances in Radiation Oncology 1 July 2023;8(4) SCOPUS ID: 2-s2.0-85153041702 07/01/2023       2 Citations
  • Normal Tissue Toxicity Prediction: Clinical Translation on the Horizon (Kerns SL, Hall WA, Marples B, West CML) Seminars in Radiation Oncology July 2023;33(3):307-316 SCOPUS ID: 2-s2.0-85158119838 07/01/2023       2 Citations
  • Normal Tissue Toxicity Prediction: Clinical Translation on the Horizon. (Kerns SL, Hall WA, Marples B, West CML) Semin Radiat Oncol 2023 Jul;33(3):307-316 PMID: 37331785 SCOPUS ID: 2-s2.0-85158119838 06/19/2023       2 Citations
  • Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. (Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA) Adv Radiat Oncol 2023;8(4):101206 PMID: 37152489 PMCID: PMC10157111 SCOPUS ID: 2-s2.0-85153041702 05/08/2023       2 Citations
  • Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial. (Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2):370-377 PMID: 37137444 PMCID: PMC10949135 SCOPUS ID: 2-s2.0-85163341124 05/04/2023       7 Citations
  • Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer. (Thalji SZ, Fernando D, Dua KS, Madhavan S, Chisholm P, Smith ZL, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Evans DB, Tsai S) Ann Surg 2023 Dec 01;278(6):e1224-e1231 PMID: 37078282 SCOPUS ID: 2-s2.0-85176508848 04/20/2023       1 Citation
  • Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity. (Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Chisholm P, Kulkarni N, Doucette S, Evans DB, Tsai S) J Surg Oncol 2023 Jul;128(1):41-50 PMID: 36960919 SCOPUS ID: 2-s2.0-85152449940 03/25/2023       2 Citations
  • CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer. (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S) Ann Surg Oncol 2023 May;30(5):3013-3021 PMID: 36788189 SCOPUS ID: 2-s2.0-85147934173 02/15/2023       1 Citation
  • Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials. (Nguyen PL, Huang HR, Spratt DE, Davicioni E, Sandler HM, Shipley WU, Efstathiou JA, Simko JP, Pollack A, Dicker AP, Roach M, Rosenthal SA, Zeitzer KL, Mendez LC, Hartford AC, Hall WA, Desai AB, Rabinovitch RA, Peters CA, Rodgers JP, Tran P, Feng FY) Int J Radiat Oncol Biol Phys 2023 Jul 01;116(3):521-529 PMID: 36596347 PMCID: PMC10281690 SCOPUS ID: 2-s2.0-85147822298 01/04/2023       12 Citations
  • Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy (Khan HY, Kamgar M, Aboukameel A, Bannoura S, Chung BY, Li Y, Hallak MNA, Philip PA, Tsai S, Luther S, Hall WA, Azmi AS) Advances in Radiation Oncology 1 January 2023;8(1) SCOPUS ID: 2-s2.0-85143485885 01/01/2023       5 Citations
  • Region-specific deep learning models for accurate segmentation of rectal structures on post-chemoradiation T2w MRI: a multi-institutional, multi-reader study (DeSilvio T, Antunes JT, Bera K, Chirra P, Le H, Liska D, Stein SL, Marderstein E, Hall W, Paspulati R, Gollamudi J, Purysko AS, Viswanath SE) Frontiers in Medicine 2023;10 SCOPUS ID: 2-s2.0-85160086975 01/01/2023       4 Citations
  • Impact of endorectal filling on interobserver variability of MRI based rectal primary tumor delineation (Lo Russo M, Nachbar M, Barry A, Bhide S, Chang A, Hall W, Intven M, Marijnen C, Peters F, Minsky B, Romesser PB, Sarkar R, Tan A, Boeke S, Wegener D, Butzer S, Boldt J, Gatidis S, Nikolaou K, Thorwarth D, Zips D, Gani C) Clinical and Translational Radiation Oncology January 2023;38:1-5 SCOPUS ID: 2-s2.0-85140066911 01/01/2023       2 Citations
  • Confirming and Refining Our Existing Postoperative Treatment Strategies Through the Use of Novel Prostate-Specific Positron Emission Tomography (PET) Imaging. (Hall WA, Lawton CAF) Int J Radiat Oncol Biol Phys 2023 Jan 01;115(1):118-119 PMID: 36526378 SCOPUS ID: 2-s2.0-85143877126 12/17/2022    
  • Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy. (Khan HY, Kamgar M, Aboukameel A, Bannoura S, Chung BY, Li Y, Hallak MNA, Philip PA, Tsai S, Luther S, Hall WA, Azmi AS) Adv Radiat Oncol 2023;8(1):101122 PMID: 36479231 PMCID: PMC9720358 SCOPUS ID: 2-s2.0-85143485885 12/09/2022       5 Citations
  • Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study-An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation Therapy. (Teunissen FR, Willigenburg T, Tree AC, Hall WA, Choi SL, Choudhury A, Christodouleas JP, de Boer JCJ, de Groot-van Breugel EN, Kerkmeijer LGW, Pos FJ, Schytte T, Vesprini D, Verkooijen HM, van der Voort van Zyp JRN) Pract Radiat Oncol 2023;13(3):e261-e269 PMID: 36462619 SCOPUS ID: 2-s2.0-85146453768 12/04/2022       14 Citations
  • Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial. (Hall WA, Evans DB, Tsai S) JAMA Oncol 2023 Feb 01;9(2):275-276 PMID: 36454556 SCOPUS ID: 2-s2.0-85148307010 12/02/2022       2 Citations
  • Re: MRI-guided Focused Ultrasound Focal Therapy for Patients with Intermediate-risk Prostate Cancer: A Phase 2b, Multicentre Study (Hall WA, Shoag J, Spratt DE) European Urology December 2022;82(6):661-662 SCOPUS ID: 2-s2.0-85139043020 12/01/2022       2 Citations
  • A Randomized, Phase II, Clinical Trial of Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable, Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma. (Saif A, Verbus E, Erickson B, Kamgar M, Tsai S, Evans D, Hernandez JM, Hall WA) Ann Surg Oncol 2023 Feb;30(2):688-690 PMID: 36427115 PMCID: PMC10688344 SCOPUS ID: 2-s2.0-85145451354 11/26/2022    
  • Achieving a Cure Without Total Mesorectal Excision in Rectal Adenocarcinoma. (Hall WA, Smith JJ) J Clin Oncol 2023 Jan 10;41(2):173-180 PMID: 36332177 PMCID: PMC9839271 SCOPUS ID: 2-s2.0-85145668656 11/05/2022       8 Citations
  • Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. (Loo Gan C, Huang J, Pan E, Xie W, Schmidt AL, Labaki C, Meza L, Bouchard G, Li H, Jackson-Spence F, Sánchez-Ruiz C, Powles T, Kumar SA, Weise N, Hall WA, Rose BS, Beuselinck B, Suarez C, Pal SK, Choueiri TK, Heng DYC, McKay RR) Eur Urol Oncol 2023 Apr;6(2):204-211 PMID: 36328934 SCOPUS ID: 2-s2.0-85151969441 11/04/2022       6 Citations
  • Corrigendum to “The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma” [Eur Urol 2022] (European Urology, (S030228382202468X), (10.1016/j.eururo.2022.06.017)) (Ali M, Mooi J, Lawrentschuk N, McKay RR, Hannan R, Lo SS, Hall WA, Siva S) European Urology November 2022;82(5):e152 SCOPUS ID: 2-s2.0-85136624037 11/01/2022    
  • Auto-detection of necessity for MRI-guided online adaptive replanning using a machine learning classifier. (Parchur AK, Lim S, Nasief HG, Omari EA, Zhang Y, Paulson ES, Hall WA, Erickson B, Li XA) Med Phys 2023 Jan;50(1):440-448 PMID: 36227732 PMCID: PMC9868055 SCOPUS ID: 2-s2.0-85140247594 10/14/2022       3 Citations
  • Predicting necessity of daily online adaptive replanning based on wavelet image features for MRI guided adaptive radiation therapy. (Nasief HG, Parchur AK, Omari E, Zhang Y, Chen X, Paulson E, Hall WA, Erickson B, Li XA) Radiother Oncol 2022 Nov;176:165-171 PMID: 36216299 PMCID: PMC9838213 SCOPUS ID: 2-s2.0-85140068136 10/11/2022       4 Citations
  • Predicting Treatment Response From Extracellular Volume Fraction for Chemoradiation Therapy of Pancreatic Cancer. (Noid G, Godfrey G, Hall W, Shah J, Paulson E, Knechtges P, Erickson B, Allen Li X) Int J Radiat Oncol Biol Phys 2023 Mar 01;115(3):803-808 PMID: 36210026 SCOPUS ID: 2-s2.0-85143525839 10/10/2022       10 Citations
  • Re: MRI-guided Focused Ultrasound Focal Therapy for Patients with Intermediate-risk Prostate Cancer: A Phase 2b, Multicentre Study. (Hall WA, Shoag J, Spratt DE) Eur Urol 2022 Dec;82(6):661-662 PMID: 36184380 SCOPUS ID: 2-s2.0-85139043020 10/03/2022       2 Citations
  • Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology. (Hall WA, Kishan AU, Hall E, Nagar H, Vesprini D, Paulson E, Van der Heide UA, Lawton CAF, Kerkmeijer LGW, Tree AC) Front Oncol 2022;12:962897 PMID: 36132128 PMCID: PMC9484536 SCOPUS ID: 2-s2.0-85138290454 09/23/2022       1 Citation
  • Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma. (Juloori A, Katipally RR, Lemons JM, Singh AK, Iyer R, Robbins JR, George B, Hall WA, Pitroda SP, Arif F, Fung J, Pillai A, Liao CY, Sharma M, Liauw SL) Int J Radiat Oncol Biol Phys 2023 Jan 01;115(1):202-213 PMID: 36108891 SCOPUS ID: 2-s2.0-85143996905 09/16/2022       34 Citations
  • Corrigendum to "The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma" [Eur Urol 2022]. (Ali M, Mooi J, Lawrentschuk N, McKay RR, Hannan R, Lo SS, Hall WA, Siva S) Eur Urol 2022 Nov;82(5):e152 PMID: 36041935 SCOPUS ID: 2-s2.0-85136624037 08/31/2022    
  • The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma. (Ali M, Mooi J, Lawrentschuk N, McKay RR, Hannan R, Lo SS, Hall WA, Siva S) Eur Urol 2022 Dec;82(6):613-622 PMID: 35843777 SCOPUS ID: 2-s2.0-85134811123 07/18/2022       36 Citations
  • Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601. (Jackson WC, Tang M, Schipper MJ, Sandler HM, Zumsteg ZS, Efstathiou JA, Shipley WU, Seiferheld W, Lukka HR, Bahary JP, Zietman AL, Pisansky TM, Zeitzer KL, Hall WA, Dess RT, Lovett RD, Balogh AG, Feng FY, Spratt DE) J Clin Oncol 2022 Sep 20;40(27):3172-3179 PMID: 35737923 PMCID: PMC9514834 SCOPUS ID: 2-s2.0-85138447340 06/24/2022       14 Citations
  • ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT/IGRT. (Damico N, Meyer J, Das P, Murphy J, Miller E, Koontz B, Hall W, McBride M, Pereira G, Catalano P, Chakravarthy AB, O'Dwyer PJ, Dorth J) Pract Radiat Oncol 2022;12(4):335-347 PMID: 35717050 SCOPUS ID: 2-s2.0-85132239599 06/19/2022       11 Citations
  • The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521. (Hall WA, Karrison TG, Rosenthal SA, Amin MB, Gomella LG, Purdy JA, Sartor AO, Michalski JM, Garzotto MG, Bergom C, Jani AB, Lawton CAF, Simko JP, Moore JK, Gore EM, Lee WR, Nguyen PL, Danielson BL, Sandler HM, Feng FY) Int J Radiat Oncol Biol Phys 2022 Oct 01;114(2):266-274 PMID: 35675855 PMCID: PMC9444930 SCOPUS ID: 2-s2.0-85136601546 06/09/2022       3 Citations
  • A Prior Knowledge-Guided, Deep Learning-Based Semiautomatic Segmentation for Complex Anatomy on Magnetic Resonance Imaging. (Zhang Y, Liang Y, Ding J, Amjad A, Paulson E, Ahunbay E, Hall WA, Erickson B, Li XA) Int J Radiat Oncol Biol Phys 2022 Oct 01;114(2):349-359 PMID: 35667525 PMCID: PMC9639200 SCOPUS ID: 2-s2.0-85136545309 06/07/2022       4 Citations
  • Adaptive Radiation Therapy Physician Guidelines: Recommendations From an Expert Users' Panel. (Kim H, Lee P, Tree AC, Chuong MD, Raldow AC, Kishan AU, Fuller CD, Rosenberg SA, Hall WA, Chie EK, Portelance L) Pract Radiat Oncol 2022;12(5):e355-e362 PMID: 35644469 SCOPUS ID: 2-s2.0-85133890110 06/02/2022       11 Citations
  • First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac. (Janssen TM, Aitken K, Alongi F, Barry A, Bernchou U, Boeke S, Hall WA, Hosni A, Kroon PS, Nachbar M, Saeed H, Jürgenliemk-Schulz IM, Schytte T, Verkooijen HM, Nowee ME, tumor site group for oligometastatic disease of the Elekta MR-Linac Consortium) Tech Innov Patient Support Radiat Oncol 2022 Jun;22:50-54 PMID: 35586786 PMCID: PMC9108982 SCOPUS ID: 2-s2.0-85129945098 05/20/2022       8 Citations
  • Technical Radiotherapy Advances – The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation (Gough J, Hall W, Good J, Nash A, Aitken K) Clinical Oncology May 2022;34(5):301-312 SCOPUS ID: 2-s2.0-85126523768 05/01/2022       5 Citations
  • Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer. (Ponce SEB, Erickson BA, Hall WA, Bedi M, Martens MJ, Siker M, Thomas J, George B, Ludwig K, Peterson C, Ridolfi T, Longo JM) J Gastrointest Oncol 2022 Feb;13(1):185-196 PMID: 35284138 PMCID: PMC8899735 SCOPUS ID: 2-s2.0-85125562951 03/15/2022       1 Citation
  • Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer (Beltrán Ponce SE, Erickson BA, Hall WA, Bedi M, Martens MJ, Siker M, Thomas J, George B, Ludwig K, Peterson C, Ridolfi T, Longo JM) Journal of Gastrointestinal Oncology February 2022;13(1):185-196 SCOPUS ID: 2-s2.0-85125562951 02/01/2022       1 Citation
  • General and custom deep learning autosegmentation models for organs in head and neck, abdomen, and male pelvis. (Amjad A, Xu J, Thill D, Lawton C, Hall W, Awan MJ, Shukla M, Erickson BA, Li XA) Med Phys 2022 Mar;49(3):1686-1700 PMID: 35094390 PMCID: PMC8917093 SCOPUS ID: 2-s2.0-85124464974 01/31/2022       18 Citations
  • Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer. (Kerns SL, Amidon Morlang A, Lee SM, Peterson DR, Marples B, Zhang H, Bylund K, Rosenzweig D, Hall W, De Ruyck K, Rosenstein BS, Stock RG, Gómez-Caamaño A, Vega A, Sosa-Fajardo P, Taboada-Valladares B, Aguado-Barrera ME, Parker C, Veldeman L, Fonteyne V, Bultijnck R, Talbot CJ, Symonds RP, Johnson K, Rattay T, Webb A, Lambrecht M, de Ruysscher D, Vanneste B, Choudhury A, Elliott RM, Sperk E, Herskind C, Veldwijk MR, Rancati T, Avuzzi B, Valdagni R, Azria D, Farcy Jacquet MP, Chang-Claude J, Seibold P, West C, Janelsins M, Chen Y, Messing E, Morrow G, REQUITE Consortium) Radiother Oncol 2022 Mar;168:75-82 PMID: 35077710 PMCID: PMC8986577 SCOPUS ID: 2-s2.0-85123912429 01/26/2022       9 Citations
  • Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126 (Hall WA, Deshmukh S, Bruner DW, Michalski JM, Purdy JA, Bosch W, Bahary JP, Patel MP, Parliament MB, Lock MI, Lau HY, Souhami L, Fisher SA, Kwok Y, Seider MJ, Vigneault E, Rosenthal SA, Gustafson GS, Gay HA, Pugh SL, Sandler HM, Movsas B) International Journal of Radiation Oncology Biology Physics 1 January 2022;112(1):83-92 SCOPUS ID: 2-s2.0-85120798535 01/01/2022       5 Citations
  • Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126. (Hall WA, Deshmukh S, Bruner DW, Michalski JM, Purdy JA, Bosch W, Bahary JP, Patel MP, Parliament MB, Lock MI, Lau HY, Souhami L, Fisher SA, Kwok Y, Seider MJ, Vigneault E, Rosenthal SA, Gustafson GS, Gay HA, Pugh SL, Sandler HM, Movsas B) Int J Radiat Oncol Biol Phys 2022 Jan 01;112(1):83-92 PMID: 34919884 PMCID: PMC8789217 SCOPUS ID: 2-s2.0-85120798535 12/18/2021       5 Citations
  • Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linac. (Daamen LA, de Mol van Otterloo SR, van Goor IWJM, Eijkelenkamp H, Erickson BA, Hall WA, Heerkens HD, Meijer GJ, Molenaar IQ, van Santvoort HC, Verkooijen HM, Intven MPW) Acta Oncol 2022 Jan;61(1):111-115 PMID: 34879792 SCOPUS ID: 2-s2.0-85121352408 12/10/2021       26 Citations
  • Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians. (Hall WA, Paulson E, Li XA, Erickson B, Schultz C, Tree A, Awan M, Low DA, McDonald BA, Salzillo T, Glide-Hurst CK, Kishan AU, Fuller CD) CA Cancer J Clin 2022 Jan;72(1):34-56 PMID: 34792808 PMCID: PMC8985054 SCOPUS ID: 2-s2.0-85119184109 11/19/2021       61 Citations
  • Characterization of Underrepresented Populations in Modern Era Clinical Trials Involving Radiation Therapy. (Bero EH, Rein LE, Banerjee A, Straza MW, Lawton CAF, Schultz CJ, Erickson BA, Siker ML, Hall WA) Pract Radiat Oncol 2021;11(6):453-459 PMID: 34742459 SCOPUS ID: 2-s2.0-85118502646 11/08/2021       6 Citations
  • Quantification and Dosimetric Impact of Normal Organ Motion During Adaptive Radiation Therapy Plan Verification Using a 1.5 Tesla Magnetic Resonance Equipped Linear Accelerator (MR LINAC) (D. Wittman, E.S. Paulson, D. Eastwood, A. Banerjee, L.I. Banla, C.J. Schultz, M.J. Awan, X. Chen, E. Omari, M.W. Straza, A. Li, B.A. Erickson, W.A. Hall) International Journal of Radiation Oncology Biology Physics D. Wittman, E.S. Paulson, D. Eastwood, A. Banerjee, L.I. Banla, C.J. Schultz, M.J. Awan, X. Chen, E. Omari, M.W. Straza, A. Li, B.A. Erickson, W.A. Hall, Quantification and Dosimetric Impact of Normal Organ Motion During Adaptive Radiation Therapy Plan Verification Using a 1.5 Tesla Magnetic Resonance Equipped Linear Accelerator (MR LINAC), International Journal of Radiation Oncology*Biology*Physics, Volume 111, Issue 3, Supplement, 2021 11/01/2021    
  • Automatically Determining Necessity of Online Adaptive Replanning Based on MRI Wavelet Multiscale Texture Features for MRI-Guided Adaptive Radiation Therapy (H. Nasief, E. Omari, Y. Zhang, X. Chen, A.K. Parchur, E.S. Paulson, W.A. Hall, B.A. Erickson, A. Li) International Journal of Radiation Oncology Biology Physics H. Nasief, E. Omari, Y. Zhang, X. Chen, A.K. Parchur, E.S. Paulson, W.A. Hall, B.A. Erickson, A. Li, Automatically Determining Necessity of Online Adaptive Replanning Based on MRI Wavelet Multiscale Texture Features for MRI-Guided Adaptive Radiation Therapy, International Journal of Radiation Oncology*Biology*Physics, Volume 111, Issue 3, Supplement, 2021 11/01/2021    
  • Development of a Comprehensive Cardiac MRI Atlas of Half Fourier-Acquired Single-Shot Turbo Spin-Echo (HASTE) and 3D Balanced Steady-State Free Precession (bSSFP) Sequences Prospectively Acquired From a 1.5T MR-Linac (A.M. Schottstaedt, E.S. Paulson, J. Rubenstein, X. Chen, E. Omari, A. Li, E.M. Gore, C.J. Schultz, W.A. Hall) International Journal of Radiation Oncology Biology Physics A.M. Schottstaedt, E.S. Paulson, J. Rubenstein, X. Chen, E. Omari, A. Li, E.M. Gore, C.J. Schultz, W.A. Hall, Development of a Comprehensive Cardiac MRI Atlas of Half Fourier-Acquired Single-Shot Turbo Spin-Echo (HASTE) and 3D Balanced Steady-State Free Precession (bSSFP) Sequences Prospectively Acquired From a 1.5T MR-Linac, International Journal of Radiation Oncology*Biology*Physics, Volume 111, Issue 3, Supplement, 2021 11/01/2021    
  • Exploring Correlation Between CT Number and ADC Value for Understanding Radiation Response (X. Chen, E.S. Paulson, M. Patel, W.A. Hall, A. Li) International Journal of Radiation Oncology Biology Physics X. Chen, E.S. Paulson, M. Patel, W.A. Hall, A. Li, Exploring Correlation Between CT Number and ADC Value for Understanding Radiation Response, International Journal of Radiation Oncology*Biology*Physics, Volume 111, Issue 3, Supplement, 2021 11/01/2021    
  • Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development? (Beinhoff P, Sabharwal L, Udhane V, Maranto C, LaViolette PS, Jacobsohn KM, Tsai S, Iczkowski KA, Wang L, Hall WA, Dehm SM, Kilari D, Nevalainen MT) Cancers (Basel) 2021 Oct 17;13(20) PMID: 34680353 PMCID: PMC8533841 SCOPUS ID: 2-s2.0-85117018634 10/24/2021       11 Citations
  • Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma. (Hall WA, Dawson LA, Hong TS, Palta M, Herman JM, Evans DB, Tsai S, Ferrone CR, B Fleming J, Chang DT, Crane C, Koong AC, Oar A, Parikh P, Erickson B, Hoffe S, Goodman KA) J Clin Oncol 2021 Dec 01;39(34):3773-3777 PMID: 34623894 PMCID: PMC8608256 SCOPUS ID: 2-s2.0-85122166787 10/09/2021       17 Citations
  • Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology. (Hall WA, Kamgar M, Erickson BA, Ponce SB, Tsai S, Nevalainen MT, Christians KK, George B, Dua KS, Khan AH, Evans DB, Azmi AS) Cancer Metastasis Rev 2021 Sep;40(3):879-889 PMID: 34611794 PMCID: PMC8767496 SCOPUS ID: 2-s2.0-85116412346 10/07/2021       2 Citations
  • Second-generation jak2 inhibitors for advanced prostate cancer: Are we ready for clinical development? (Beinhoff P, Sabharwal L, Udhane V, Maranto C, Laviolette PS, Jacobsohn KM, Tsai S, Iczkowski KA, Wang L, Hall WA, Dehm SM, Kilari D, Nevalainen MT) Cancers October-2 2021;13(20) SCOPUS ID: 2-s2.0-85117018634 10/01/2021       11 Citations
  • Evolving Concepts Regarding Radiation Therapy for Pancreatic Cancer. (Hall WA, Erickson B, Crane CH) Surg Oncol Clin N Am 2021 Oct;30(4):719-730 PMID: 34511192 PMCID: PMC8462521 SCOPUS ID: 2-s2.0-85114667482 09/14/2021       4 Citations
  • Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group (van Houdt PJ, Saeed H, Thorwarth D, Fuller CD, Hall WA, McDonald BA, Shukla-Dave A, Kooreman ES, Philippens MEP, van Lier ALHMW, Keesman R, Mahmood F, Coolens C, Stanescu T, Wang J, Tyagi N, Wetscherek A, van der Heide UA) European Journal of Cancer August 2021;153:64-71 SCOPUS ID: 2-s2.0-85107945729 08/01/2021       27 Citations
  • Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional Registry. (de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Daamen LA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Philippens MEP, Sahgal A, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Tseng CL, Hall WA, Verkooijen HM, MR-Linac Consortium) Int J Radiat Oncol Biol Phys 2021 Nov 15;111(4):867-875 PMID: 34265394 PMCID: PMC9764331 SCOPUS ID: 2-s2.0-85113219681 07/16/2021       33 Citations
  • Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial. (Rahma OE, Yothers G, Hong TS, Russell MM, You YN, Parker W, Jacobs SA, Colangelo LH, Lucas PC, Gollub MJ, Hall WA, Kachnic LA, Vijayvergia N, O'Rourke MA, Faller BA, Valicenti RK, Schefter TE, George S, Kainthla R, Stella PJ, Sigurdson E, Wolmark N, George TJ) JAMA Oncol 2021 Aug 01;7(8):1225-1230 PMID: 34196693 PMCID: PMC8251652 SCOPUS ID: 2-s2.0-85113344164 07/02/2021       106 Citations
  • Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group. (van Houdt PJ, Saeed H, Thorwarth D, Fuller CD, Hall WA, McDonald BA, Shukla-Dave A, Kooreman ES, Philippens MEP, van Lier ALHMW, Keesman R, Mahmood F, Coolens C, Stanescu T, Wang J, Tyagi N, Wetscherek A, van der Heide UA) Eur J Cancer 2021 Aug;153:64-71 PMID: 34144436 PMCID: PMC8340311 SCOPUS ID: 2-s2.0-85107945729 06/19/2021       27 Citations
  • Early Comparative Toxicity Outcomes of Patients With Prostate Cancer Receiving Initial Cryotherapy and Radiotherapy Salvage (Jiang C, Godette K, Hall WA, Bennett JK, Rossi P, Cooper S, Jani AB, Patel PR) Clinical Genitourinary Cancer June 2021;19(3):267-270.e1 SCOPUS ID: 2-s2.0-85096167136 06/01/2021       2 Citations
  • Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions. (Hall WA, Small C, Paulson E, Koay EJ, Crane C, Intven M, Daamen LA, Meijer GJ, Heerkens HD, Bassetti M, Rosenberg SA, Aitken K, Myrehaug S, Dawson LA, Lee P, Gani C, Chuong MD, Parikh PJ, Erickson BA) Front Oncol 2021;11:628155 PMID: 34046339 PMCID: PMC8144850 SCOPUS ID: 2-s2.0-85107182435 05/29/2021       26 Citations
  • In Reply to Onal et al. (Hall WA, Lawton CAF, coauthors) Int J Radiat Oncol Biol Phys 2021 Jun 01;110(2):620-621 PMID: 33989589 SCOPUS ID: 2-s2.0-85105339930 05/15/2021    
  • The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change? (Ryckman JM, Reames BN, Klute KA, Hall WA, Baine MJ, Abdel-Wahab M, Lin C) Clin Transl Radiat Oncol 2021 May;28:124-128 PMID: 33981865 PMCID: PMC8085778 SCOPUS ID: 2-s2.0-85104326512 05/14/2021       6 Citations
  • The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change? (Ryckman JM, Reames BN, Klute KA, Hall WA, Baine MJ, Abdel-Wahab M, Lin C) Clinical and Translational Radiation Oncology May 2021;28:124-128 SCOPUS ID: 2-s2.0-85104326512 05/01/2021       6 Citations
  • MRI-Guided Radiation Therapy. (Lee SL, Hall WA, Morris ZS, Christensen L, Bassetti M) Adv Oncol 2021 May;1:29-39 PMID: 37064601 PMCID: PMC10104451 05/01/2021    
  • Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial. (Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF) Pract Radiat Oncol 2021;11(6):527-533 PMID: 33848618 PMCID: PMC8638529 SCOPUS ID: 2-s2.0-85107984420 04/14/2021       3 Citations
  • Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial. (Feng FY, Huang HC, Spratt DE, Zhao SG, Sandler HM, Simko JP, Davicioni E, Nguyen PL, Pollack A, Efstathiou JA, Dicker AP, Todorovic T, Margrave J, Liu YS, Dabbas B, Thompson DJS, Das R, Dignam JJ, Sweeney C, Attard G, Bahary JP, Lukka HR, Hall WA, Pisansky TM, Shah AB, Pugh SL, Shipley WU, Tran PT) JAMA Oncol 2021 Apr 01;7(4):544-552 PMID: 33570548 PMCID: PMC7879385 SCOPUS ID: 2-s2.0-85100750925 02/12/2021       85 Citations
  • Considering benefit and risk before routinely recommending SpaceOAR. (Hall WA, Tree AC, Dearnaley D, Parker CC, Prasad V, Roach M 3rd, Lawton CAF) Lancet Oncol 2021 Jan;22(1):11-13 PMID: 33387489 PMCID: PMC8882263 SCOPUS ID: 2-s2.0-85098657879 01/03/2021       28 Citations
  • Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods. (Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S) Am J Surg 2021 Jul;222(1):10-17 PMID: 33308823 SCOPUS ID: 2-s2.0-85097458297 12/15/2020       48 Citations
  • A Patient-Specific Autosegmentation Strategy Using Multi-Input Deformable Image Registration for Magnetic Resonance Imaging-Guided Online Adaptive Radiation Therapy: A Feasibility Study. (Zhang Y, Paulson E, Lim S, Hall WA, Ahunbay E, Mickevicius NJ, Straza MW, Erickson B, Li XA) Adv Radiat Oncol 2020;5(6):1350-1358 PMID: 33305098 PMCID: PMC7718500 SCOPUS ID: 2-s2.0-85097125143 12/12/2020       23 Citations
  • Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer (Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S) HPB December 2020;22(12):1745-1752 SCOPUS ID: 2-s2.0-85083782398 12/01/2020       2 Citations
  • Early Comparative Toxicity Outcomes of Patients With Prostate Cancer Receiving Initial Cryotherapy and Radiotherapy Salvage. (Jiang C, Godette K, Hall WA, Bennett JK, Rossi P, Cooper S, Jani AB, Patel PR) Clin Genitourin Cancer 2021 Jun;19(3):267-270.e1 PMID: 33191148 SCOPUS ID: 2-s2.0-85096167136 11/17/2020       2 Citations
  • A Patient-Specific Autosegmentation Strategy Using Multi-Input Deformable Image Registration for Magnetic Resonance Imaging–Guided Online Adaptive Radiation Therapy: A Feasibility Study (Zhang Y, Paulson E, Lim S, Hall WA, Ahunbay E, Mickevicius NJ, Straza MW, Erickson B, Li XA) Advances in Radiation Oncology 1 November 2020;5(6):1350-1358 SCOPUS ID: 2-s2.0-85097125143 11/01/2020       23 Citations
  • Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate. (Hall WA, Fishbane N, Liu Y, Xu MJ, Davicioni E, Mahal BA, Den RB, Dess RT, Jackson WC, Wong AC, Schaeffer EM, Karnes RJ, Carroll PR, Cooperberg MR, Bismar TA, Kim HL, Klein EA, Davis JW, Ross AE, Tosoian JJ, Morgan TM, Mehra R, Salami SS, Nguyen PL, Lawton CAF, Spratt DE, Feng F) JCO Precis Oncol 2020 Nov;4:1228-1238 PMID: 35050780 SCOPUS ID: 2-s2.0-85095822574 11/01/2020       3 Citations
  • ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortium. (Kooreman ES, van Houdt PJ, Keesman R, Pos FJ, van Pelt VWJ, Nowee ME, Wetscherek A, Tijssen RHN, Philippens MEP, Thorwarth D, Wang J, Shukla-Dave A, Hall WA, Paulson ES, van der Heide UA) Radiother Oncol 2020 Dec;153:106-113 PMID: 33017604 PMCID: PMC8327388 SCOPUS ID: 2-s2.0-85092917458 10/06/2020       59 Citations
  • The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy. (de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM) Front Oncol 2020;10:1328 PMID: 33014774 PMCID: PMC7505056 SCOPUS ID: 2-s2.0-85091425211 10/06/2020       76 Citations
  • Total Neoadjuvant Therapy for Operable Pancreatic Cancer. (Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S) Ann Surg Oncol 2021 Apr;28(4):2246-2256 PMID: 33000372 SCOPUS ID: 2-s2.0-85091728559 10/02/2020       33 Citations
  • The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy (de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM) Frontiers in Oncology 7 September 2020;10 SCOPUS ID: 2-s2.0-85091425211 09/07/2020       76 Citations
  • Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer (Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S) Surgery (United States) September 2020;168(3):440-447 SCOPUS ID: 2-s2.0-85087345792 09/01/2020       15 Citations
  • NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer. (Hall WA, Paulson E, Davis BJ, Spratt DE, Morgan TM, Dearnaley D, Tree AC, Efstathiou JA, Harisinghani M, Jani AB, Buyyounouski MK, Pisansky TM, Tran PT, Karnes RJ, Chen RC, Cury FL, Michalski JM, Rosenthal SA, Koontz BF, Wong AC, Nguyen PL, Hope TA, Feng F, Sandler HM, Lawton CAF) Int J Radiat Oncol Biol Phys 2021 Jan 01;109(1):174-185 PMID: 32861817 PMCID: PMC7736505 SCOPUS ID: 2-s2.0-85092542250 08/31/2020       87 Citations
  • Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer. (Krepline AN, Geurts JL, George B, Kamgar M, Madhavan S, Erickson BA, Hall WA, Griffin MO, Evans DB, Tsai S, Kim RY) Surgery 2021 Mar;169(3):629-635 PMID: 32826069 SCOPUS ID: 2-s2.0-85089521842 08/23/2020       6 Citations
  • Cytokines, JAK-STAT Signaling and Radiation-Induced DNA Repair in Solid Tumors: Novel Opportunities for Radiation Therapy. (Hall WA, Sabharwal L, Udhane V, Maranto C, Nevalainen MT) Int J Biochem Cell Biol 2020 Oct;127:105827 PMID: 32822847 PMCID: PMC8638530 SCOPUS ID: 2-s2.0-85090734995 08/22/2020       8 Citations
  • Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac. (Hall WA, Straza MW, Chen X, Mickevicius N, Erickson B, Schultz C, Awan M, Ahunbay E, Li XA, Paulson ES) PLoS One 2020;15(8):e0236570 PMID: 32764748 PMCID: PMC7413561 SCOPUS ID: 2-s2.0-85089301005 08/09/2020       54 Citations
  • Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer. (Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S) Surgery 2020 Sep;168(3):440-447 PMID: 32641278 SCOPUS ID: 2-s2.0-85087345792 07/10/2020       15 Citations
  • 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience (Paulson ES, Ahunbay E, Chen X, Mickevicius NJ, Chen GP, Schultz C, Erickson B, Straza M, Hall WA, Li XA) Clinical and Translational Radiation Oncology July 2020;23:72-79 SCOPUS ID: 2-s2.0-85084968086 07/01/2020       91 Citations
  • 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience. (Paulson ES, Ahunbay E, Chen X, Mickevicius NJ, Chen GP, Schultz C, Erickson B, Straza M, Hall WA, Li XA) Clin Transl Radiat Oncol 2020 Jul;23:72-79 PMID: 32490218 PMCID: PMC7256110 SCOPUS ID: 2-s2.0-85084968086 06/04/2020       91 Citations
  • Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy. (Barnes CA, Aldakkak M, Clarke CN, Christians KK, Bucklan D, Holt M, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) Front Oncol 2020;10:500 PMID: 32363161 PMCID: PMC7180175 SCOPUS ID: 2-s2.0-85084152103 05/05/2020       12 Citations
  • Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer. (Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S) HPB (Oxford) 2020 Dec;22(12):1745-1752 PMID: 32354656 SCOPUS ID: 2-s2.0-85083782398 05/02/2020       2 Citations
  • Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer. (Wittmann D, Hall WA, Christians KK, Barnes CA, Jariwalla NR, Aldakkak M, Clarke CN, George B, Ritch PS, Riese M, Khan AH, Kulkarni N, Evans J, Erickson BA, Evans DB, Tsai S) Front Oncol 2020;10:460 PMID: 32351886 PMCID: PMC7175033 SCOPUS ID: 2-s2.0-85084010622 05/01/2020       21 Citations
  • Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer. (Dess RT, Sun Y, Jackson WC, Jairath NK, Kishan AU, Wallington DG, Mahal BA, Stish BJ, Zumsteg ZS, Den RB, Hall WA, Gharzai LA, Jaworski EM, Reichert ZR, Morgan TM, Mehra R, Schaeffer EM, Sartor O, Nguyen PL, Lee WR, Rosenthal SA, Michalski JM, Schipper MJ, Dignam JJ, Pisansky TM, Zietman AL, Sandler HM, Efstathiou JA, Feng FY, Shipley WU, Spratt DE) JAMA Oncol 2020 May 01;6(5):735-743 PMID: 32215583 PMCID: PMC7189892 SCOPUS ID: 2-s2.0-85082524498 03/28/2020       64 Citations
  • Dose-Escalated Radiation Therapy for Pancreatic Cancer: A Simultaneous Integrated Boost Approach. (Koay EJ, Hanania AN, Hall WA, Taniguchi CM, Rebueno N, Myrehaug S, Aitken KL, Dawson LA, Crane CH, Herman JM, Erickson B) Pract Radiat Oncol 2020;10(6):e495-e507 PMID: 32061993 PMCID: PMC7423616 SCOPUS ID: 2-s2.0-85082820455 02/18/2020       48 Citations
  • Auto-segmentation of pancreatic tumor in multi-parametric MRI using deep convolutional neural networks. (Liang Y, Schott D, Zhang Y, Wang Z, Nasief H, Paulson E, Hall W, Knechtges P, Erickson B, Li XA) Radiother Oncol 2020 Apr;145:193-200 PMID: 32045787 SCOPUS ID: 2-s2.0-85078961399 02/12/2020       60 Citations
  • Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9. (Nasief H, Hall W, Zheng C, Tsai S, Wang L, Erickson B, Li XA) Front Oncol 2019;9:1464 PMID: 31970088 PMCID: PMC6960122 SCOPUS ID: 2-s2.0-85078248047 01/24/2020       38 Citations
  • MRI-Based Upper Abdominal Organs-at-Risk Atlas for Radiation Oncology. (Lukovic J, Henke L, Gani C, Kim TK, Stanescu T, Hosni A, Lindsay P, Erickson B, Khor R, Eccles C, Boon C, Donker M, Jagavkar R, Nowee ME, Hall WA, Parikh P, Dawson LA) Int J Radiat Oncol Biol Phys 2020 Mar 15;106(4):743-753 PMID: 31953061 SCOPUS ID: 2-s2.0-85077930009 01/19/2020       23 Citations
  • Development and validation of a genomic tool to predict seminal vesicle invasion in adenocarcinoma of the prostate (Hall WA, Fishbane N, Liu Y, Xu MJ, Davicioni E, Mahal BA, Den RB, Dess RT, Jackson WC, Wong AC, Schaeffer EM, Karnes RJ, Carroll PR, Cooperberg MR, Bismar TA, Kim HL, Klein EA, Davis JW, Ross AE, Tosoian JJ, Morgan TM, Mehra R, Salami SS, Nguyen PL, Lawton CAF, Spratt DE, Feng F) JCO Precision Oncology 2020;4:1228-1238 SCOPUS ID: 2-s2.0-85095822574 01/01/2020       3 Citations
  • Opportunities and Challenges of Genomically Guided Decision Making for Patients With Prostate Cancer. (Hall WA) Pract Radiat Oncol 2020;10(2):93-94 PMID: 31760164 SCOPUS ID: 2-s2.0-85077660698 11/25/2019    
  • Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice? (Krepline AN, Bliss L, Geurts J, Akinola I, Christians KK, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2020 Feb;24(2):235-242 PMID: 31745905 SCOPUS ID: 2-s2.0-85076028351 11/21/2019       10 Citations
  • The transformation of radiation oncology using real-time magnetic resonance guidance: A review. (Hall WA, Paulson ES, van der Heide UA, Fuller CD, Raaymakers BW, Lagendijk JJW, Li XA, Jaffray DA, Dawson LA, Erickson B, Verheij M, Harrington KJ, Sahgal A, Lee P, Parikh PJ, Bassetti MF, Robinson CG, Minsky BD, Choudhury A, Tersteeg RJHA, Schultz CJ, MR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium) Eur J Cancer 2019 Nov;122:42-52 PMID: 31614288 PMCID: PMC8447225 SCOPUS ID: 2-s2.0-85073099937 10/16/2019       134 Citations
  • A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer. (Nasief H, Zheng C, Schott D, Hall W, Tsai S, Erickson B, Allen Li X) NPJ Precis Oncol 2019;3:25 PMID: 31602401 PMCID: PMC6778189 SCOPUS ID: 2-s2.0-85116956561 10/12/2019       110 Citations
  • A preferred patient decubitus positioning for magnetic resonance image guided online adaptive radiation therapy of pancreatic cancer (Chen Y, Chen X, Hall W, Prior P, Zhang Y, Paulson E, Lang J, Erickson B, Li XA) Physics and Imaging in Radiation Oncology October 2019;12:22-29 SCOPUS ID: 2-s2.0-85075203914 10/01/2019       1 Citation
  • Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902. (Hamstra DA, Pugh SL, Lepor H, Rosenthal SA, Pienta KJ, Gomella L, Peters C, D'Souza DP, Zeitzer KL, Jones CU, Hall WA, Horwitz E, Pisansky TM, Souhami L, Hartford AC, Dominello M, Feng F, Sandler HM) Radiother Oncol 2019 Dec;141:137-143 PMID: 31540746 PMCID: PMC6912855 SCOPUS ID: 2-s2.0-85072167922 09/22/2019       9 Citations
  • Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. (Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, Parekh A, Patton C, Pepek JM, Salama JK, Tuli R, Koong AC) Pract Radiat Oncol 2019;9(5):322-332 PMID: 31474330 SCOPUS ID: 2-s2.0-85070874820 09/03/2019       117 Citations
  • Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline (Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, Parekh A, Patton C, Pepek JM, Salama JK, Tuli R, Koong AC) Practical Radiation Oncology September - October 2019;9(5):322-332 SCOPUS ID: 2-s2.0-85070874820 09/01/2019       117 Citations
  • Estimation of changing gross tumor volume from longitudinal CTs during radiation therapy delivery based on a texture analysis with classifier algorithms: a proof-of-concept study. (Schott D, Schmidt TG, Hall W, Knechtges P, Noid G, Klawikowski S, Erickson B, Li XA) Quant Imaging Med Surg 2019 Jul;9(7):1189-1200 PMID: 31448206 PMCID: PMC6685807 SCOPUS ID: 2-s2.0-85076403234 08/27/2019    
  • Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review. (Borkenhagen JF, Eastwood D, Kilari D, See WA, Van Wickle JD, Lawton CA, Hall WA) J Natl Compr Canc Netw 2019 Jul 01;17(7):829-837 PMID: 31319388 SCOPUS ID: 2-s2.0-85070084884 07/19/2019       10 Citations
  • Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. (Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK) Surgery 2019 Sep;166(3):277-285 PMID: 31272811 SCOPUS ID: 2-s2.0-85068174272 07/06/2019       45 Citations
  • Serial T2-Weighted Magnetic Resonance Images Acquired on a 1.5 Tesla Magnetic Resonance Linear Accelerator Reveal Radiomic Feature Variation in Organs at Risk: An Exploratory Analysis of Novel Metrics of Tissue Response in Prostate Cancer. (Lorenz JW, Schott D, Rein L, Mostafaei F, Noid G, Lawton C, Bedi M, Li XA, Schultz CJ, Paulson E, Hall WA) Cureus 2019 Apr 20;11(4):e4510 PMID: 31259119 PMCID: PMC6590865 07/02/2019    
  • Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy. (Hall WA, Goodman KA) Radiat Oncol 2019 Jun 26;14(1):114 PMID: 31242912 PMCID: PMC6595558 SCOPUS ID: 2-s2.0-85068910566 06/28/2019       27 Citations
  • Corrigendum to "Imaging predictors of treatment outcomes in rectal cancer: An overview" [Crit. Rev. Oncol./Hematol. 129, (September) (2018), 153-162]. (ShreeMahadevan L, Zhong J, Venkatesulu B, Kaur H, Bhide S, Minsky B, Chu W, Intven M, van der Heide UA, Triest B, Krishnan S, Hall W) Crit Rev Oncol Hematol 2019 Feb;134:71 PMID: 30771876 SCOPUS ID: 2-s2.0-85059585890 02/18/2019    
  • Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial. (Bruner DW, Pugh SL, Lee WR, Hall WA, Dignam JJ, Low D, Swanson GP, Shah AB, Malone S, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Pisansky TM, Chen Y, Sandler HM, Movsas B) JAMA Oncol 2019 May 01;5(5):664-670 PMID: 30763425 PMCID: PMC6459051 SCOPUS ID: 2-s2.0-85061649437 02/15/2019       38 Citations
  • Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5: Comparing Apples to Oranges: A Self-fulfilling Prophecy? (Kishan AU, Hall WA, Spratt DE) Eur Urol 2019 May;75(5):e133-e134 PMID: 30670312 SCOPUS ID: 2-s2.0-85063631193 01/24/2019    
  • Neoadjuvant Chemoradiation for Localized Pancreatic Cancer (Hall WA, Erickson BA) Management of Localized Pancreatic Cancer: Current Treatment and Challenges 1 January 2019:85-96 SCOPUS ID: 2-s2.0-85150146639 01/01/2019    
  • Role of Radiation for Locally Advanced Pancreatic Cancer (Erickson BA, Hall WA) Management of Localized Pancreatic Cancer: Current Treatment and Challenges 1 January 2019:113-132 SCOPUS ID: 2-s2.0-85150131315 01/01/2019    
  • Variations of MRI-assessed peristaltic motions during radiation therapy. (Mostafaei F, Tai A, Omari E, Song Y, Christian J, Paulson E, Hall W, Erickson B, Li XA) PLoS One 2018;13(10):e0205917 PMID: 30359413 PMCID: PMC6201905 SCOPUS ID: 2-s2.0-85055472031 10/26/2018       38 Citations
  • Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. (Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB) Ann Surg 2020 Apr;271(4):740-747 PMID: 30312198 SCOPUS ID: 2-s2.0-85082099572 10/13/2018       129 Citations
  • Imaging predictors of treatment outcomes in rectal cancer: An overview. (Mahadevan LS, Zhong J, Venkatesulu B, Kaur H, Bhide S, Minsky B, Chu W, Intven M, van der Heide UA, van Triest B, Krishnan S, Hall WA) Crit Rev Oncol Hematol 2018 Sep;129:153-162 PMID: 30097234 SCOPUS ID: 2-s2.0-85050493718 08/12/2018       17 Citations
  • PET-based Treatment Response Assessment for Neoadjuvant Chemoradiation in Pancreatic Adenocarcinoma: An Exploratory Study. (Dalah E, Tai A, Oshima K, Hall WA, Erickson B, Li XA) Transl Oncol 2018 Oct;11(5):1104-1109 PMID: 30015263 PMCID: PMC6070701 SCOPUS ID: 2-s2.0-85049778422 07/18/2018       20 Citations
  • Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease. (Kolarich A, George TJ Jr, Hughes SJ, Delitto D, Allegra CJ, Hall WA, Chang GJ, Tan SA, Shaw CM, Iqbal A) Cancer 2018 Sep 01;124(17):3510-3519 PMID: 29984547 PMCID: PMC10450543 SCOPUS ID: 2-s2.0-85050944697 07/10/2018       65 Citations
  • Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer. (McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD, See WA, LaViolette PS) Int J Radiat Oncol Biol Phys 2018 Aug 01;101(5):1179-1187 PMID: 29908785 PMCID: PMC6190585 SCOPUS ID: 2-s2.0-85048748761 06/18/2018       45 Citations
  • Radiation biology and oncology in the genomic era. (Kerns SL, Chuang KH, Hall W, Werner Z, Chen Y, Ostrer H, West C, Rosenstein B) Br J Radiol 2018 Nov;91(1091):20170949 PMID: 29888979 PMCID: PMC6475928 SCOPUS ID: 2-s2.0-85053833312 06/12/2018       20 Citations
  • Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review. (Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA) Neurosurgery 2018 May 01;82(5):595-603 PMID: 29669114 SCOPUS ID: 2-s2.0-85068839760 04/19/2018       10 Citations
  • Neoadjuvant chemoradiation for operable pancreatic cancer: The importance of local disease control (Barnes CA, Tsai S, Hall WA, Erickson BA, Evans DB) Pancreatic Cancer 11 April 2018:1219-1237 SCOPUS ID: 2-s2.0-85054042785 04/11/2018    
  • Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes. (Hall WA, Pugh SL, Wefel JS, Armstrong TS, Gilbert MR, Brachman DG, Werner-Wasik M, Wendland MM, Brown PD, Chao ST, Roof KS, Robins HI, Mehta MP, Curran WJ Jr, Movsas B) Neurosurgery 2019 Jan 01;84(1):66-76 PMID: 29618054 PMCID: PMC6500905 SCOPUS ID: 2-s2.0-85059287141 04/05/2018       8 Citations
  • Correlation of ADC With Pathological Treatment Response for Radiation Therapy of Pancreatic Cancer. (Dalah E, Erickson B, Oshima K, Schott D, Hall WA, Paulson E, Tai A, Knechtges P, Li XA) Transl Oncol 2018 Apr;11(2):391-398 PMID: 29455085 PMCID: PMC5852406 SCOPUS ID: 2-s2.0-85044783020 02/20/2018       39 Citations
  • Pancreatic gross tumor volume contouring on computed tomography (CT) compared with magnetic resonance imaging (MRI): Results of an international contouring conference. (Hall WA, Heerkens HD, Paulson ES, Meijer GJ, Kotte AN, Knechtges P, Parikh PJ, Bassetti MF, Lee P, Aitken KL, Palta M, Myrehaug S, Koay EJ, Portelance L, Ben-Josef E, Erickson BA) Pract Radiat Oncol 2018;8(2):107-115 PMID: 29426692 SCOPUS ID: 2-s2.0-85043352148 02/11/2018       20 Citations
  • Locally advanced pancreas cancer: Staging and goals of therapy. (Chatzizacharias NA, Tsai S, Griffin M, Tolat P, Ritch P, George B, Barnes C, Aldakkak M, Khan AH, Hall W, Erickson B, Evans DB, Christians KK) Surgery 2018 May;163(5):1053-1062 PMID: 29331400 SCOPUS ID: 2-s2.0-85040254084 01/15/2018       47 Citations
  • Adaptive radiation dose escalation in rectal adenocarcinoma: a review. (Van Wickle JD, Paulson ES, Landry JC, Erickson BA, Hall WA) J Gastrointest Oncol 2017 Oct;8(5):902-914 PMID: 29184696 PMCID: PMC5674246 SCOPUS ID: 2-s2.0-85031666657 12/01/2017       19 Citations
  • Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. (Delitto D, George TJ Jr, Loftus TJ, Qiu P, Chang GJ, Allegra CJ, Hall WA, Hughes SJ, Tan SA, Shaw CM, Iqbal A) J Natl Cancer Inst 2018 May 01;110(5):460-466 PMID: 29165692 PMCID: PMC6279292 SCOPUS ID: 2-s2.0-85055889091 11/23/2017       17 Citations
  • The role of imaging in the clinical practice of radiation oncology for pancreatic cancer. (Koay EJ, Hall W, Park PC, Erickson B, Herman JM) Abdom Radiol (NY) 2018 Feb;43(2):393-403 PMID: 29110053 PMCID: PMC5832555 SCOPUS ID: 2-s2.0-85033451392 11/08/2017       6 Citations
  • Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging. (Hurrell SL, McGarry SD, Kaczmarowski A, Iczkowski KA, Jacobsohn K, Hohenwalter MD, Hall WA, See WA, Banerjee A, Charles DK, Nevalainen MT, Mackinnon AC, LaViolette PS) J Med Imaging (Bellingham) 2018 Jan;5(1):011004 PMID: 29098169 PMCID: PMC5658575 SCOPUS ID: 2-s2.0-85032902519 11/04/2017       37 Citations
  • Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. (Hall WA, Bergom C, Thompson RF, Baschnagel AM, Vijayakumar S, Willers H, Li XA, Schultz CJ, Wilson GD, West CML, Capala J, Coleman CN, Torres-Roca JF, Weidhaas J, Feng FY) Int J Radiat Oncol Biol Phys 2018 Jun 01;101(2):274-284 PMID: 28964588 SCOPUS ID: 2-s2.0-85030158569 10/02/2017       51 Citations
  • Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer? (Blitzer GC, Hall WA, Tsai S, Aldakkak M, Hellman RS, Evans DB, Christians KK, George B, Ritch PS, Erickson BA) Pract Radiat Oncol 2017;7(6):e449-e455 PMID: 28886941 SCOPUS ID: 2-s2.0-85028763165 09/10/2017    
  • Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? (Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2017 Nov;21(11):1793-1803 PMID: 28849366 SCOPUS ID: 2-s2.0-85028529403 08/30/2017       26 Citations
  • Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study. (Chen X, Oshima K, Schott D, Wu H, Hall W, Song Y, Tao Y, Li D, Zheng C, Knechtges P, Erickson B, Li XA) PLoS One 2017;12(6):e0178961 PMID: 28575105 PMCID: PMC5456365 SCOPUS ID: 2-s2.0-85020175046 06/03/2017       69 Citations
  • Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. (Zhong J, Patel K, Switchenko J, Cassidy RJ, Hall WA, Gillespie T, Patel PR, Kooby D, Landry J) Cancer 2017 Sep 15;123(18):3486-3493 PMID: 28493288 PMCID: PMC5589506 SCOPUS ID: 2-s2.0-85019056922 05/12/2017       96 Citations
  • Considerations Regarding the Role of Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma in the Elderly. (Hall WA, Erickson B) J Oncol Pract 2017 Mar;13(3):171-172 PMID: 28282275 SCOPUS ID: 2-s2.0-85016831760 03/11/2017    
  • Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer. (Heerkens HD, Hall WA, Li XA, Knechtges P, Dalah E, Paulson ES, van den Berg CAT, Meijer GJ, Koay EJ, Crane CH, Aitken K, van Vulpen M, Erickson BA) Pract Radiat Oncol 2017;7(2):126-136 PMID: 28089481 SCOPUS ID: 2-s2.0-85009476334 01/17/2017       44 Citations
  • Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy. (Hall WA, Lawton CA, Jani AB, Pollack A, Feng FY) Semin Radiat Oncol 2017 Jan;27(1):11-20 PMID: 27986207 SCOPUS ID: 2-s2.0-85006751493 12/18/2016       10 Citations
  • Outcome Analysis of Treatment in Stage IIA, T3N0 Rectal Adenocarcinoma in the Veterans Health Administration (VHA) (W.A. Hall, D. Lans, C. Arce-Lara, M.J. Kelley, R. Santana-Davila, D.M. Marcus, S. Tsai, T. Ridolfi, B.A. Erickson, E.M. Gore) International Journal of Radiation Oncology, Biology, Physics 10/01/2016    
  • Correlation of ADC Texture With Treatment Response for Chemoradiation Therapy of Pancreatic Cancer (D. Schott W.A. Hall T. Gilat Schmidt E. Dalah K. Oshima E.S. Paulson P.M. Knechtges B.A. Erickson A. Li) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S70, OCTOBER 01, 2016 10/01/2016    
  • Pancreatic Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Radiomic Metrics Correlate With Pathologic Molecular Markers: An Exploratory Analysis (W.A. Hall E.S. Paulson A. Vistocky S. Tsai E.J. Koay P.M. Knechtges D. Evans K. Christians P. Ritch B. George K. Oshima A. Li B.A. Erickson) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E178-E179, OCTOBER 01, 2016 10/01/2016    
  • A Computed Tomography Imaging Feature of Pancreatic Cancer As a Predictive Biomarker for Escalated Dose Radiation Therapy (S. Moningi A. Amer L.E. Colbert Y. Lee W.A. Hall B.A. Erickson G.R. Varadhachary P. Das C.M. Taniguchi J.B. Fleming M. Katz C.H. Crane E.J. Koay) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E171-E172, OCTOBER 01, 2016 10/01/2016    
  • NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results (D. Watkins Bruner S.L. Pugh W.R. Lee J.J. Dignam D. Low G.P. Swanson A.B. Shah D.P. D'Souza J.M. Michalski I.S. Dayes S.A. Seaward P.L. Nguyen W.A. Hall T.M. Pisansky Y. Chen H.M. Sandler B. Movsas ) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S2-S3, OCTOBER 01, 2016 10/01/2016    
  • Radiation for Pancreatic Adenocarcinoma: An End-of-Life Treatment? Assessing Appropriate Radiation Therapy Utilization in the National Cancer Data Base (NCDB) (L.E. Colbert K.V. Dharmarajan J. Switchenko C.M. Taniguchi W.A. Hall T.W. Gillespie D.A. Kooby J. Lipscomb J.C. Landry) International Journal of Radiation Oncology, Biology, Physics EPOSTER ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , S195, OCTOBER 01, 2016 10/01/2016    
  • TNFRSF10C copy number variation is associated with metastatic colorectal cancer. (Tanenbaum DG, Hall WA, Colbert LE, Bastien AJ, Brat DJ, Kong J, Kim S, Dwivedi B, Kowalski J, Landry JC, Yu DS) J Gastrointest Oncol 2016 Jun;7(3):306-14 PMID: 27284460 PMCID: PMC4880759 SCOPUS ID: 2-s2.0-84995758211 06/11/2016       15 Citations
  • The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. (Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB ) Cancer. 2013 Sep 15;119(18):3272-9 08/13/2015    
  • Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. (Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC) Cancer. 2014 Feb 15;120(4):499-506 PMID: 24390739 08/13/2015    
  • Chromodomain Helicase Binding Protein 5 (CHD5) Is Associated With Improved Overall Survival In Patients Undergoing Adjuvant Therapy For Resected Pancreatic Adenocarcinoma. (Hall WA, Hardy CW, Colbert LE, Landry JC, Fisher SB, Sarka B, Petrova AV, Pantazides BG, Maithel SK, Kowalski J, Gandhi K, Kooby D, El-Rayes BF, Staley CA, Adsay V, Yu DS.) Oncogene. ePub Nov 25, 2013. PMID: 24276239. 08/13/2015    
  • Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base. (Mikell JL, Gillespie TW, Hall WA, Nickleach DC, Liu Y, Lipscomb J, Ramalingam SS, Rajpara RS, Force SD, Fernandez FG, Owonikoko TK, Pillai RN, Khuri FR, Curran WJ, Higgins KA) J Thorac Oncol 2015 Mar;10(3):462-71 PMID: 25384064 PMCID: PMC4336617 SCOPUS ID: 2-s2.0-84938287585 11/11/2014       93 Citations
  • Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia. (Mikell JL, Waller EK, Switchenko JM, Rangaraju S, Ali Z, Graiser M, Hall WA, Langston AA, Esiashvili N, Khoury HJ, Khan MK) Int J Radiat Oncol Biol Phys 2014 Jun 01;89(2):360-9 PMID: 24837891 SCOPUS ID: 2-s2.0-84899859754 05/20/2014       11 Citations
  • The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. (Hall WA, Colbert LE, Nickleach D, Switchenko J, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC) J Gastrointest Oncol 2014 Apr;5(2):77-85 PMID: 24772334 PMCID: PMC3999628 SCOPUS ID: 2-s2.0-84995745328 04/29/2014       13 Citations
  • Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate. (Hall WA, Colbert L, Nickleach D, Shelton J, Marcus DM, Switchenko J, Rossi PJ, Godette K, Cooper S, Jani AB) Pract Radiat Oncol 2013;3(4):e157-64 PMID: 24674413 PMCID: PMC10388692 SCOPUS ID: 2-s2.0-84884354185 03/29/2014       12 Citations
  • CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer. (Colbert LE, Petrova AV, Fisher SB, Pantazides BG, Madden MZ, Hardy CW, Warren MD, Pan Y, Nagaraju GP, Liu EA, Saka B, Hall WA, Shelton JW, Gandhi K, Pauly R, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS) Cancer Res 2014 May 15;74(10):2677-87 PMID: 24626090 PMCID: PMC4025946 SCOPUS ID: 2-s2.0-84901278176 03/15/2014       33 Citations
  • Dose--volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol. (Chen AM, Wang PC, Daly ME, Cui J, Hall WH, Vijayakumar S, Phillips TL, Farwell DG, Purdy JA) Int J Radiat Oncol Biol Phys 2014 Mar 15;88(4):771-7 PMID: 24606846 SCOPUS ID: 2-s2.0-84895766377 03/13/2014       42 Citations
  • Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. (Prabhu RS, Hanasoge S, Magliocca KR, Hall WA, Chen SA, Higgins KA, Saba NF, El-Deiry M, Grist W, Wadsworth JT, Chen AY, Beitler JJ) Head Neck 2015 Jun;37(6):777-82 PMID: 24596123 SCOPUS ID: 2-s2.0-84929909838 03/07/2014       58 Citations
  • Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection. (Prabhu RS, Hanasoge S, Magliocca KR, Moeller BJ, Milas ZL, Hall WA, El-Deiry M, Wadsworth JT, Higgins KA, Beitler JJ) Cancer 2014 May 15;120(10):1499-506 PMID: 24510454 SCOPUS ID: 2-s2.0-84899976013 02/11/2014       54 Citations
  • Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. (Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC) Cancer 2014 Feb 15;120(4):499-506 PMID: 24390739 PMCID: PMC4380170 SCOPUS ID: 2-s2.0-84893716303 01/07/2014       39 Citations
  • Accuracy of computed tomography for predicting pathologic nodal extracapsular extension in patients with head-and-neck cancer undergoing initial surgical resection. (Prabhu RS, Magliocca KR, Hanasoge S, Aiken AH, Hudgins PA, Hall WA, Chen SA, Eaton BR, Higgins KA, Saba NF, Beitler JJ) Int J Radiat Oncol Biol Phys 2014 Jan 01;88(1):122-9 PMID: 24331658 SCOPUS ID: 2-s2.0-84890496892 12/18/2013       80 Citations
  • Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. (Hall WA, Petrova AV, Colbert LE, Hardy CW, Fisher SB, Saka B, Shelton JW, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Volkan Adsay N, Curran WJ, Landry JC, Maithel SK, Yu DS) Oncogene 2014 Nov 20;33(47):5450-6 PMID: 24276239 SCOPUS ID: 2-s2.0-84887905533 11/28/2013       18 Citations
  • The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. (Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB) Cancer 2013 Sep 15;119(18):3272-9 PMID: 23818401 SCOPUS ID: 2-s2.0-84883600886 07/03/2013       34 Citations
  • Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma. (Colbert LE, Fisher SB, Hardy CW, Hall WA, Saka B, Shelton JW, Petrova AV, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS) Cancer 2013 Sep 01;119(17):3148-55 PMID: 23720157 PMCID: PMC4389890 SCOPUS ID: 2-s2.0-84882635576 05/31/2013       102 Citations
  • The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma. (Hall WA, Colbert LE, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC) Cancer 2013 Jun 15;119(12):2350-7 PMID: 23625519 PMCID: PMC3904231 SCOPUS ID: 2-s2.0-84878590347 04/30/2013       12 Citations
  • Clinical outcomes for a novel 6 degrees of freedom image guided localization method for frameless radiosurgery for intracranial brain metastases. (Prabhu RS, Dhabaan A, Hall WA, Ogunleye T, Crocker I, Curran WJ, Shu HK) J Neurooncol 2013 May;113(1):93-9 PMID: 23440526 SCOPUS ID: 2-s2.0-84876917007 02/27/2013       22 Citations
  • Tumor size on abdominal MRI versus pathologic specimen in resected pancreatic adenocarcinoma: implications for radiation treatment planning. (Hall WA, Mikell JL, Mittal P, Colbert L, Prabhu RS, Kooby DA, Nickleach D, Hanley K, Sarmiento JM, Ali AN, Landry JC) Int J Radiat Oncol Biol Phys 2013 May 01;86(1):102-7 PMID: 23290442 SCOPUS ID: 2-s2.0-84876117637 01/08/2013       32 Citations
  • Treatment efficiency of volumetric modulated arc therapy in comparison with intensity-modulated radiotherapy in the treatment of prostate cancer. (Hall WA, Fox TH, Jiang X, Prabhu RS, Rossi PJ, Godette K, Jani AB) J Am Coll Radiol 2013 Feb;10(2):128-34 PMID: 23245437 SCOPUS ID: 2-s2.0-84928096449 12/19/2012       16 Citations
  • Association of clinical response and long-term outcome among patients with biopsied orbital pseudotumor receiving modern radiation therapy. (Prabhu RS, Kandula S, Liebman L, Wojno TH, Hayek B, Hall WA, Shu HK, Crocker I) Int J Radiat Oncol Biol Phys 2013 Mar 01;85(3):643-9 PMID: 22836055 SCOPUS ID: 2-s2.0-84873317064 07/28/2012       20 Citations
  • Clinical outcomes of radiotherapy as initial local therapy for Graves' ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery. (Prabhu RS, Liebman L, Wojno T, Hayek B, Hall WA, Crocker I) Radiat Oncol 2012 Jun 19;7:95 PMID: 22713684 PMCID: PMC3485155 SCOPUS ID: 2-s2.0-84862275680 06/21/2012       31 Citations
  • Comparing central nervous system (CNS) and extra-CNS hemangiopericytomas in the Surveillance, Epidemiology, and End Results program: analysis of 655 patients and review of current literature. (Hall WA, Ali AN, Gullett N, Crocker I, Landry JC, Shu HK, Prabhu R, Curran W) Cancer 2012 Nov 01;118(21):5331-8 PMID: 22517327 SCOPUS ID: 2-s2.0-84867878319 04/21/2012       15 Citations
  • Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control. (Prabhu R, Shu HK, Hadjipanayis C, Dhabaan A, Hall W, Raore B, Olson J, Curran W, Oyesiku N, Crocker I) Int J Radiat Oncol Biol Phys 2012 May 01;83(1):e61-6 PMID: 22516387 SCOPUS ID: 2-s2.0-84859837774 04/21/2012       65 Citations
  • Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review. (Hall WA, Stapleford LJ, Hadjipanayis CG, Curran WJ, Crocker I, Shu HK) Int J Surg Oncol 2011;2011:979214 PMID: 22312536 PMCID: PMC3263656 02/09/2012    
  • The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. (Hall WH, Jani AB, Ryu JK, Narayan S, Vijayakumar S) Prostate Cancer Prostatic Dis 2005;8(1):22-30 PMID: 15700051 SCOPUS ID: 2-s2.0-20444448516 02/09/2005       116 Citations
    • Last update: 07/02/2024